Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05978583 · ClinicalTrials.gov registry record
Impact of Physical and Occupational Therapy in New BMT Patients
A clinical trial of Bone Marrow Transplantation and Bone Marrow Disease, sponsored by UNC Lineberger Comprehensive Cancer Center.
- Completed
- Registry status
- 75
- Enrollment target
- 1
- Study location
NCT05978583: Completed study of Bone Marrow Transplantation and Bone Marrow Disease, sponsored by UNC Lineberger Comprehensive Cancer Center.
NCT05978583 is a study of Bone Marrow Transplantation and Bone Marrow Disease that has completed, run by UNC Lineberger Comprehensive Cancer Center. The registered enrollment target is 75 participants, below the 338-participant average among 5 other Bone Marrow Transplantation trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05978583, a study of Bone Marrow Transplantation and Bone Marrow Disease, has completed, sponsored by UNC Lineberger Comprehensive Cancer Center.
- COMPLETED
- Registry status
- 75 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a single-site, non-randomized, observational study designed to evaluate the impact of adding physical and occupational therapy consultation upon inpatient admission for a bone marrow transplantation (BMT). The purpose of this study is to investigate whether consultation with physical and occupational therapists as part of the general admission order set for patients scheduled for bone marrow transplant will result in reduced complications, morbidity, length of inpatient stay, 30-day readmission, and 90-day mortality. Baseline data collection will be used to determine eligibility. This study will be partially retrospective (pre-implementation of physical and occupational therapy consultation order) and partially prospective.
Primary Outcome
30-day readmission rates will be calculated using historical data (pre-intervention) and compared to rates once physical and occupational therapy consultation has been included in the inpatient admission order set for bone marrow transplantation (BMT).
Conditions Studied
Study Locations (1)
North Carolina
- Lineberger Comphrehensive Cancer Center at University of North Carolina at Chapel Hill - Chapel Hill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2023-01-01 |
| Est. Completion | 2024-12-04 |
What the finished NCT05978583 record still lists
NCT05978583 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 75 participants, a relatively small participant target, below the 338-participant average among 5 other Bone Marrow Transplantation trials with a reported enrollment target (78% lower).
The record links to 2 conditions, with Bone Marrow Transplantation appearing as the primary indexed condition, and to 0 interventions.
NCT05978583 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT05978583 about?
NCT05978583 is a clinical study titled "Impact of Physical and Occupational Therapy in New BMT Patients". This is a single-site, non-randomized, observational study designed to evaluate the impact of adding physical and occupational therapy consultation upon inpatient admission for a bone marrow transplantation (BMT). The purpose of this study is to investigate whether consultation with physical and occ...
What is the current status of trial NCT05978583?
This trial is currently completed. The enrollment target is 75 participants. The study started on 2023-01-01. Estimated completion is 2024-12-04.
What conditions does trial NCT05978583 study?
This clinical trial studies the following conditions: Bone Marrow Transplantation, Bone Marrow Disease.
Who is sponsoring clinical trial NCT05978583?
This trial is sponsored by UNC Lineberger Comprehensive Cancer Center, which has 366 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05978583 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bone Marrow Transplantation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Biomarkers in Transplant Recipients to Improve Outcomes
RECRUITING
-
Education Program to Manage Emotional Stress of Stem Cell Transplant Recipients and Their Caregivers
COMPLETED · Phase 1
-
Collection of Samples and Data for the National Marrow Donor Program Repository
COMPLETED
-
An Adaptive Phase I Study to Evaluate the Safety, Efficacy and Dose Responses of Ronacaleret in Healthy Human Volunteers
COMPLETED · Phase 1
-
Valacyclovir in Immunocompromised Children
COMPLETED · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01535430 · 75 participants
Assessment of Eloquent Function in Brain Tumor Patients
- NCT01542879 · 75 participants · Phase 1
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
- NCT02232191 · 75 participants · Phase 2
Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients
- NCT02754544 · 75 participants · NA
Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI